Nxera Pharma Co Ltd (4565)

Currency in JPY
970.0
+14.0(+1.46%)
Closed·

Nxera Pharma (4565) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral

Technical Indicators

Buy

Moving Averages

Sell

Summary:Neutral

Moving Averages:SellBuy: (2)Sell: (10)
Technical Indicators:BuyBuy: (4)Sell: (3)

Technical Indicators

Summary: BuyBuy: 4Neutral: 3Sell: 3
Jun 16, 2026 23:27 GMT
Name
Value
Action
RSI(14)47.957Neutral
STOCH(9,6)69.675Buy
STOCHRSI(14)84.917Overbought
MACD(12,26)-2.4Sell
ADX(14)25.209Sell
Williams %R-45Buy
CCI(14)26.6898Neutral
ATR(14)9.3571Less Volatility
Highs/Lows(14)0Neutral
Ultimate Oscillator52.913Buy
ROC-1.322Sell
Bull/Bear Power(13)0.982Buy

Moving Averages

Summary: SellBuy: 2Sell: 10
Jun 16, 2026 23:27 GMT
Name
Simple
Exponential
MA5
971.2
Sell
969.3
Buy
MA10
965.9
Buy
970.3
Sell
MA20
972.8
Sell
970.7
Sell
MA50
977.4
Sell
979.1
Sell
MA100
994.8
Sell
1004.6
Sell
MA200
1070.2
Sell
1019.9
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic963965968970973975978
Fibonacci965966.9968.1970971.9973.1975
Camarilla969.6970.1970.5970971.5971.9972.4
Woodie's963.4965.2968.4970.2973.4975.2978.4
DeMark's--968.5970.2973.5--

FAQ

Is Nxera Pharma (4565) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Nxera Pharma buy/sell signal is Strong Sell.

What Do The Current Moving Averages for Nxera Pharma (4565) Show?

The moving averages for Nxera Pharma show a Sell outlook, considering moving averages ranging from MA5 to MA200, with 3 Buy signals and 9 Sell signals.

What Do Today's Technical Indicators for Nxera Pharma Show?

The technical indicators for Nxera Pharma are in a Strong Sell position based on daily analysis, with 0 signals on buy indicators and 9 sell signals.

What Is Nxera Pharma (4565)'s 14-Day RSI?

The current Relative Strength Index (RSI) of 4565 over the 14-day period is 47.957, which suggests that the stock is a Neutral.

What Is Nxera Pharma (4565)'s MACD?

4565's MACD (Moving Average Convergence/Divergence) is -2.400, which suggests that the stock is a Sell.

What Is Nxera Pharma (4565)'s 5-Day Moving Average?

4565's 5-day moving average is 971.2, suggesting that the stock is a Sell.

What Is Nxera Pharma (4565)'s 50-Day Moving Average?

4565's 50-day moving average is 977.4, suggesting that the stock is a Sell.

What Is Nxera Pharma (4565)'s 200-Day Moving Average?

4565's 200-day moving average is 1070.2, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for Nxera Pharma (4565)?

The Fibonacci pivot point performance value for 4565 is 970.0.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.